Propranolol-resistant infantile haemangiomas. - Wikidata - wikimedia - TriplyDB

Propranolol-resistant infantile haemangiomas.

Propranolol-resistant infantile haemangiomas.

http://www.wikidata.org/entity/Q44668179

about

Infantile Hemangioma: A Brief Review Signaling pathways in the development of infantile hemangioma Surgical management of large scalp infantile hemangiomas.Management of periorbital hemangioma by intralesional glucocorticoids and systemic propranolol: a single-center retrospective study Beta blockers: an innovation in the treatment of infantile hemangiomas.Management of infantile hemangiomas: current trends Propranolol targets the contractility of infantile haemangioma-derived pericytes.Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.Expression of Cathepsins B, D, and G in Infantile Hemangioma.A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.Use of propranolol for parotid hemangioma.

P2860

Q26777301-44FD23E9-9AEB-4410-907F-8DE7AA5FD531 Q26996608-1C7A646E-11F0-49CC-B392-4A31C7DD9C95 Q33585186-43847188-5321-49B5-8C41-A2585316ED01 Q33756270-503BD4B4-0DAE-4E8A-B520-E211D6672144 Q33931306-88309179-3490-4C72-90CC-15147F796B9A Q34052390-C997134B-25F6-4B19-B797-4C1870B1A18B Q34323894-0B3AA0A9-4982-4511-A837-23F552FD9DCD Q36164771-CCB960D6-9B48-4FCF-8E0B-7BB7C694F7A8 Q36211734-CD252217-1C1F-40B7-91AD-1584FE4583FC Q38246692-392848F2-7D38-4739-AC2F-27E68931655F Q38293740-F34C4886-63B0-43E0-BE49-5FE149CB1636 Q40424734-1B962E9E-AB49-40A3-B8EF-F6F6D44A3811 Q40773699-76576A96-4242-4D1A-936A-745499A43FBC Q42035380-FB215707-EE03-46EE-BB04-422F77046964 Q52583419-11CD8FEA-76D6-49E6-8B9B-5FBBBC501DC7 Q53008897-519F3346-B8BB-4639-AF64-D6F0CBB7E917 Q53804973-56B14D87-AE48-4721-A665-C816FF38D96E

P2860

Propranolol-resistant infantile haemangiomas.

http://www.wikidata.org/entity/Q44668179

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Propranolol-resistant infantile haemangiomas.

@en

Propranolol-resistant infantile haemangiomas.

@nl

type

label

Propranolol-resistant infantile haemangiomas.

@en

Propranolol-resistant infantile haemangiomas.

@nl

prefLabel

Propranolol-resistant infantile haemangiomas.

@en

Propranolol-resistant infantile haemangiomas.

@nl

P1433

Q44668179-92FEC430-BD2B-4793-9D53-97ECCD0A95FC

P1476

Q44668179-2E31212B-24AF-4E98-96B7-8781B0308337

P2093

Q44668179-0EC17C23-F48D-4E51-8886-AD4B1A786214

Q44668179-1BCC9EB7-02C6-4B03-A184-A6D8C4597244

Q44668179-2F6D89B8-CAC5-401A-98DF-4D97BEFFA247

Q44668179-5ABD6B8F-58E1-4FC3-8D00-1C1386560258

Q44668179-5CABF35D-D14F-455C-B7F1-5B9863C4317E

Q44668179-7C3FCC7D-12AF-4779-BECC-224F73A02D42

Q44668179-928C5E2F-45BB-4AF4-8669-698217B6CC49

Q44668179-9CB89CFD-3B35-4DAA-95D7-2E109AD1B54F

Q44668179-C2FE4D87-608D-4975-BCD8-110474DA97F4

Q44668179-CDE131AC-DF40-4BDB-A5A2-E76961526072

P2860

Q44668179-07A22549-FF53-4429-B2E4-1AFAAD82176D

Q44668179-217D05AE-DB84-4625-9468-8F375041DFFE

Q44668179-244E77BD-24E2-4A41-8A50-355358ED1756

Q44668179-283BFBCC-8A55-49FB-8D7C-C0AA76D5982C

Q44668179-3543A2FE-F922-4CC6-8C4F-808E873B7F88

Q44668179-40787A0B-C2BC-4687-9226-74C286590F10

Q44668179-45790395-A11D-495A-B789-4FE7C9B7CD2A

Q44668179-58AAC6B3-82A8-48C7-8E4E-A3D4B1589911

Q44668179-5DE6200A-1D90-41FA-B1D0-679E373EB36A

Q44668179-62E6AE40-22D0-4457-ADE6-C9028B2708DF

P304

Q44668179-96CEFDB7-1E5F-46D9-BC18-33B85B825B83

P31

Q44668179-E7F72BE9-AB44-4659-8616-E5C6F6C42EA4

P356

Q44668179-E40D949E-002F-461C-8F26-366075279735

P407

Q44668179-F53FC1F7-55EB-4BA4-ABAC-01F56D749B29

P433

Q44668179-17F4EA68-7BF0-4B15-8517-D7FD6030A640

P478

Q44668179-77690529-16C6-43B0-97D4-2CA1BF64F56E

P50

Q44668179-D0DB48C4-CEFA-4792-81DA-12B5EE4D40E7

Q44668179-F49319E8-6FCC-4F64-B2FB-E3B9A8432BD1

P577

Q44668179-0C6DDB3F-BEAC-4A88-A1D1-4A4016605C6B

P5875

Q44668179-49C400BB-E879-479F-AAE6-D35BF92A326D

P698

Q44668179-051CFCAA-3ABE-4129-BED0-D1C73DEDA8D2

P356

P1433

British Journal of Dermatology

P1476

Propranolol-resistant infantile haemangiomas

@en

P2093

A Maruani

http://www.w3.org/2001/XMLSchema#string

A-C Bursztejn

http://www.w3.org/2001/XMLSchema#string

C Chiaverini

http://www.w3.org/2001/XMLSchema#string

C Eschard

http://www.w3.org/2001/XMLSchema#string

E Mahé

http://www.w3.org/2001/XMLSchema#string

E Puzenat

http://www.w3.org/2001/XMLSchema#string

Groupe de Recherche Clinique en Dermatologie Pédiatrique

http://www.w3.org/2001/XMLSchema#string

H Aubert

http://www.w3.org/2001/XMLSchema#string

I Dreyfus

http://www.w3.org/2001/XMLSchema#string

J Mazereeuw-Hautier

http://www.w3.org/2001/XMLSchema#string

P2860

GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas

Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.

An infantile bronchial hemangioma unresponsive to propranolol therapy: case report and literature review.

Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.

Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex.

Infantile hemangiomas: how common are they? A systematic review of the medical literature.

Propranolol therapy for infantile haemangiomas: review of the literature.

Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas.

Propranolol as first-line treatment of head and neck hemangiomas.

Propranolol for infantile haemangiomas: a review.

P304

125-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJD.12417

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Smail Hadj-rabia

Sébastien Barbarot

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262043514

http://www.w3.org/2001/XMLSchema#string

P698

23659587

http://www.w3.org/2001/XMLSchema#string